India’s Dedicated Medical Isotope Reactor in Visakhapatnam Likely to Begin Production by 2035
India’s proposed medical isotope reactor in Visakhapatnam, Andhra Pradesh, is expected to begin production around 2035, marking a significant step…
Prostate-Specific Membrane Antigen
Read More
Novartis India introduces Pluvicto, Country’s First Approved Radioligand Therapy for Advanced Prostate Cancer
Novartis India has launched Pluvicto (lutetium-177 vipivotide tetraxetan), marking the introduction of India’s first regulatory-approved radioligand therapy for eligible patients…